News‎ > ‎

Meningitis B Vaccine

posted Jun 23, 2015, 1:50 PM by Emily Koenig   [ updated Apr 24, 2016, 9:26 AM by Lorrie Laskey ]

PLEASE SHOW YOUR SUPPORT FOR ROUTINE INTRODUCTION OF MENINGITIS B VACCINES IN THE US

The Advisory Committee on Immunization Practices (ACIP) will meet tomorrow, June 24, to discuss and vote on forthcoming recommendations for the new Meningitis B vaccines. In February of 2015, the CDC agreed to provide these two new vaccines to those “most at risk.” This current meeting will consider broader recommendations such as making the vaccines routine for adolescents. 

Can you imagine losing your only child to a vaccine-preventable disease? If the Advisory Committee on Immunization Practices (ACIP) had recommended the Meningitis C vaccine for adolescents back in 2002, our daughter, Emily, could still be alive. Back in 2003, after Emily suddenly died at the age of 12, my husband and I made a public testimony before the CDC that influenced a change in those guidelines. As a result, the ACIP changed the recommended age group for vaccinations to include adolescents starting at age 11.  

The Global Members of CoMO (Confederation of Meningitis Organizations) will be submitting an important letter to the ACIP committee to help influence this very important decision tomorrow morning.  Click here to read it and help us to Join Hands Against Meningitis. We also have a member of CoMO attending the meeting to give a public testimony about the loss of her daughter to the Meninigitis B strain. You can help by sharing this information within your social networks.

We also implore you to go to the National Meningitis Association’s website, click here, and support all of our endeavors to advocate for vaccinations by signing the petition and leaving any comments you may have.

 If you are interested in listening to the meeting discussions, you can click here to obtain information about dialing into the discussion which will occur between 8:30 and 11:30 tomorrow morning.

Thanks for your support.

The Koenigs

Comments